Belgian Pharmaceuticals & Biotech Most Popular Stocks

argenx

Market Cap: €31.0b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

UCB

Market Cap: €30.7b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Financière de Tubize

Market Cap: €5.7b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

Hyloris Pharmaceuticals

Market Cap: €173.0m

Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.

European Medical Solutions

Market Cap: €19.9m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.

Celyad Oncology

Market Cap: €18.0m

A biotechnology company, focuses on research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.

BioSenic

Market Cap: €1.2m

A biotech company, focuses on developing clinical assets.

Oxurion

Market Cap: €306.6k

A biopharmaceutical company, develops medicines to prevent blindness in Belgium.